Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1967 2
1969 1
1973 1
1976 2
1979 2
1981 4
1983 2
1984 3
1985 2
1986 5
1987 5
1988 7
1989 6
1990 9
1991 4
1992 8
1993 16
1994 5
1995 27
1996 21
1997 16
1998 15
1999 14
2000 12
2001 19
2002 17
2003 15
2004 16
2005 14
2006 22
2007 22
2008 23
2009 21
2010 23
2011 25
2012 21
2013 29
2014 32
2015 28
2016 29
2017 36
2018 37
2019 41
2020 38
2021 35
2022 28
2023 27
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Results by year

Filters applied: . Clear all
Page 1
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Watanabe J, Muro K, Shitara K, Yamazaki K, Shiozawa M, Ohori H, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Hihara M, Soeda J, Misumi T, Yamamoto K, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Watanabe J, et al. Among authors: takashima a. JAMA. 2023 Apr 18;329(15):1271-1282. doi: 10.1001/jama.2023.4428. JAMA. 2023. PMID: 37071094 Free PMC article. Clinical Trial.
Current Targeted Therapy for Metastatic Colorectal Cancer.
Ohishi T, Kaneko MK, Yoshida Y, Takashima A, Kato Y, Kawada M. Ohishi T, et al. Among authors: takashima a. Int J Mol Sci. 2023 Jan 15;24(2):1702. doi: 10.3390/ijms24021702. Int J Mol Sci. 2023. PMID: 36675216 Free PMC article. Review.
Review: Chronic endometritis and its effect on reproduction.
Kimura F, Takebayashi A, Ishida M, Nakamura A, Kitazawa J, Morimune A, Hirata K, Takahashi A, Tsuji S, Takashima A, Amano T, Tsuji S, Ono T, Kaku S, Kasahara K, Moritani S, Kushima R, Murakami T. Kimura F, et al. Among authors: takashima a. J Obstet Gynaecol Res. 2019 May;45(5):951-960. doi: 10.1111/jog.13937. Epub 2019 Mar 6. J Obstet Gynaecol Res. 2019. PMID: 30843321 Review.
Tau Oligomers.
Maeda S, Takashima A. Maeda S, et al. Among authors: takashima a. Adv Exp Med Biol. 2019;1184:373-380. doi: 10.1007/978-981-32-9358-8_27. Adv Exp Med Biol. 2019. PMID: 32096050 Review.
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
Hashimoto T, Takayanagi D, Yonemaru J, Naka T, Nagashima K, Yatabe Y, Shida D, Hamamoto R, Kleeman SO, Leedham SJ, Maughan T, Takashima A, Shiraishi K, Sekine S. Hashimoto T, et al. Among authors: takashima a. Br J Cancer. 2022 Oct;127(6):1043-1050. doi: 10.1038/s41416-022-01880-w. Epub 2022 Jun 17. Br J Cancer. 2022. PMID: 35715628 Free PMC article.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Kuboki Y, Terazawa T, Masuishi T, Nakamura M, Watanabe J, Ojima H, Makiyama A, Kotaka M, Hara H, Kagawa Y, Sugimoto N, Kawakami H, Takashima A, Kajiwara T, Oki E, Sunakawa Y, Ishihara S, Taniguchi H, Nakajima TE, Morita S, Shirao K, Takenaka N, Ozawa D, Yoshino T. Kuboki Y, et al. Among authors: takashima a. Br J Cancer. 2023 May;128(10):1897-1905. doi: 10.1038/s41416-023-02212-2. Epub 2023 Mar 4. Br J Cancer. 2023. PMID: 36871043 Free PMC article. Clinical Trial.
Tauopathies and tau oligomers.
Takashima A. Takashima A. J Alzheimers Dis. 2013;37(3):565-8. doi: 10.3233/JAD-130653. J Alzheimers Dis. 2013. PMID: 23948895 Review.
Evaluation of short-term epigenetic age fluctuation.
Komaki S, Ohmomo H, Hachiya T, Sutoh Y, Ono K, Furukawa R, Umekage S, Otsuka-Yamasaki Y, Minabe S, Takashima A, Tanno K, Sasaki M, Shimizu A. Komaki S, et al. Among authors: takashima a. Clin Epigenetics. 2022 Jun 9;14(1):76. doi: 10.1186/s13148-022-01293-9. Clin Epigenetics. 2022. PMID: 35681206 Free PMC article.
Targeting the RAS oncogene.
Takashima A, Faller DV. Takashima A, et al. Expert Opin Ther Targets. 2013 May;17(5):507-31. doi: 10.1517/14728222.2013.764990. Epub 2013 Jan 30. Expert Opin Ther Targets. 2013. PMID: 23360111 Free PMC article. Review.
721 results